2015 GI Cancers Symposium - Saturday
Read More
Adam M Lee, Ph.D., Mayo Clinic, Rochester, MN, presenting "Abstract 508: HapB3 and the deep intronic variant c.1129-5923 C>G of the dihydropyrimidine dehydrogenase gene (DPYD) to predict toxicity in stage III colon cancer (CC) patients (pts) (NCCTG Alliance N0147),"
San Francisco, CA - 2015 Gastrointestinal Cancers Symposium : Adam M Lee, Ph.D., Mayo Clinic, Rochester, MN, presenting "Abstract 508: HapB3 and the deep intronic variant c.1129-5923 C>G of the dihydropyrimidine dehydrogenase gene (DPYD) to predict toxicity in stage III colon cancer (CC) patients (pts) (NCCTG Alliance N0147)," during Translational Research Session: Understanding Molecular Testing at the Gastrointestinal Cancers Symposium 2015 here today, Saturday January 17, 2015. The Symposium is supported by ASCO, the American Society of Clinical Oncology, ASTRO, The American Society of Radiation Oncology, SSO, Society of Surgical Oncology and the AGA Institute. Over 3,000 physicians, researchers and allied healthcare professionals are attending the meeting which is being held at the Moscone West center in San Francisco and features the latest Gastrointestinal Cancers research in the areas of basic and clinical science. Date: Saturday January 17, 2015. Photo by © ASCO/Todd Buchanan 2015 Technical Questions: todd@medmeetingimages.com; Phone: 612-226-5154. GI15_DailyNews
